Privia Health Group, Inc. $PRVA Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 5.1% during the second quarter, Holdings Channel reports. The firm owned 1,948,021 shares of the company’s stock after selling 103,638 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Privia Health Group were worth $50,123,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Bayban acquired a new stake in shares of Privia Health Group during the fourth quarter worth about $26,000. Public Employees Retirement System of Ohio purchased a new stake in shares of Privia Health Group in the second quarter valued at approximately $26,000. Hantz Financial Services Inc. increased its holdings in shares of Privia Health Group by 456.2% in the 4th quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock valued at $27,000 after purchasing an additional 926 shares in the last quarter. Global Retirement Partners LLC lifted its position in shares of Privia Health Group by 579.8% during the 4th quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock valued at $38,000 after acquiring an additional 1,351 shares during the period. Finally, Allworth Financial LP acquired a new position in Privia Health Group during the second quarter worth $48,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Citigroup reiterated a “buy” rating on shares of Privia Health Group in a research report on Thursday, July 23rd. Zacks Research upgraded shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Wednesday, August 5th. Barclays cut their target price on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 26th. Weiss Ratings raised shares of Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 2nd. Finally, Canaccord Genuity Group set a $32.00 target price on Privia Health Group in a research report on Friday, August 7th. Eleven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $31.00.

Insider Activity

In other Privia Health Group news, CFO David Mountcastle sold 21,275 shares of the firm’s stock in a transaction dated Thursday, July 9th. The shares were sold at an average price of $27.67, for a total value of $588,679.25. Following the transaction, the chief financial officer owned 164,853 shares of the company’s stock, valued at $4,561,482.51. This trade represents a 11.43% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Matthew Shawn Morris sold 53,722 shares of the firm’s stock in a transaction that occurred on Monday, July 6th. The stock was sold at an average price of $27.24, for a total value of $1,463,387.28. Following the completion of the sale, the director directly owned 68,188 shares in the company, valued at approximately $1,857,441.12. This trade represents a 44.07% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 327,886 shares of company stock worth $8,628,256. 5.70% of the stock is owned by company insiders.

Privia Health Group Price Performance

Shares of PRVA stock opened at $20.72 on Thursday. The firm has a market cap of $2.65 billion, a P/E ratio of 98.67, a P/E/G ratio of 1.63 and a beta of 0.87. Privia Health Group, Inc. has a 1-year low of $19.53 and a 1-year high of $28.82. The firm has a fifty day moving average of $24.14 and a two-hundred day moving average of $23.17.

Privia Health Group (NASDAQ:PRVA) last released its earnings results on Thursday, August 6th. The company reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.12. Privia Health Group had a return on equity of 3.52% and a net margin of 1.19%.The company had revenue of $632.63 million for the quarter, compared to the consensus estimate of $597.33 million. During the same quarter last year, the business posted $0.24 EPS. Privia Health Group’s quarterly revenue was up 21.4% compared to the same quarter last year. On average, sell-side analysts expect that Privia Health Group, Inc. will post 0.27 EPS for the current year.

Privia Health Group Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.